STOUGHTON, Mass., April 11, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the 22 Annual Needham Healthcare Conference being held…Read More
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
